Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from v3.5.2 to v3.5.3, reflecting a platform/version update rather than substantive study content changes.
    Difference
    0.0%
    Check dated 2026-04-24T05:51:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    - Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:20:29.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    UI/layout adjustments and a timestamp update are visible on the study page. No substantive data such as eligibility criteria, endpoints, enrollment, or site information appears to have changed.
    Difference
    0.0%
    Check dated 2026-04-02T14:58:25.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0, a UI/metadata update that does not alter the study information.
    Difference
    0.0%
    Check dated 2026-03-18T22:53:31.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3, indicating a minor maintenance update.
    Difference
    0.0%
    Check dated 2026-03-11T18:48:47.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government-funding notice and the prior Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T11:11:20.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.